COVID-19 Research Paper Volume 13, Issue 12 pp 15785—15800

Clinical characterization and therapeutic targets of vitamin A in patients with hepatocholangiocarcinoma and coronavirus disease

MetaboAnalyst analysis showed the targeted metabolic pathways by VA against CHOL/COVID-19.

Figure 5. MetaboAnalyst analysis showed the targeted metabolic pathways by VA against CHOL/COVID-19.